The role of viral and host genetics in natural history and treatment of chronic HCV infection

Grants

Funding Acknowledgements

JD, AT and MH acknowledges fellowship support from the National Health and Medical Research Council (NHMRC). JD and MH acknowledge the contribution to this work of the NHMRC Centre for Research Excellence in Injecting Drug Use and the Victorian Operational Infrastructure Support Program (Department of Health, Victoria, Australia) to the Burnet Institute.MH: Research support - Roche.AT: Research/grant support - Merck, Roche Pharmaceuticals, Gilead Sciences; Consulting/advisory capacity - Merck, Roche Pharmaceuticals, Janssen-Cilag (Johnson and Johnson); Speaker's fee - Merck, Roche Pharmaceuticals, Bristol-Myers Squibb. Co-inventor of a patent related to the IL28B HCV discovery.